5.640EUR+6.01%Mkt Cap: 215.12M EURP/E: —Last update: 2026-06-01
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap215.12M EUR
Enterprise Value202.23M EUR
Revenue (TTM)23.47M EUR
Gross Profit24.05M EUR
Net Income (TTM)-34.07M EUR
Revenue/Share0.6390 EUR
Last Price5.640 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees199
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011049824
Valuation
P/E (Trailing)—
P/E (Forward)-13.08
PEG—
EV/EBITDA-14.34
EV/Revenue8.62
P/S8.65
P/B-5.56
EPS (TTM)-0.93
EPS (Forward)-0.41
52W Range
1.19273% of range7.270
52W High7.270 EUR
52W Low1.192 EUR
Profitability
Gross Margin102.98%
Oper. Margin-57.75%
EBITDA Margin-60.09%
Profit Margin-145.85%
ROE96.92%
ROA-94.97%
Growth
Revenue Growth0.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.43M EUR
CapEx (TTM)747.00K EUR
FCF Margin35.44%
FCF Yield3.87%
Net Debt6.91M EUR
Net Debt/EBITDA-0.49
Balance Sheet
Debt/Equity-0.62
Current Ratio0.67
Quick Ratio0.65
Book Value/Sh-0.9570 EUR
Cash/Share0.5010 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)12.97 EUR
Target Range10.00 EUR – 17.00 EUR
# Analysts3
Ownership
Shares Out.38.14M
Float30.51M
Insiders13.13%
Institutions9.54%
Technical
SMA 504.832 (+16.7%)
SMA 2004.013 (+40.5%)
Beta0.57
S&P 52W Chg27.94%
Avg Vol (30d)343.10K
Avg Vol (10d)530.92K
Technical Indicators
RSI (14)52.6
MACD0.1860
MACD Signal0.1767
MACD Hist.+0.0092
BB Upper5.878 EUR
BB Middle5.199 EUR
BB Lower4.521 EUR
BB Width26.11%
ATR (14)0.3910 EUR
Vol Ratio (20d)1.28x